NOD1 and diabetes mellitus: Additionally, network pharmacology, GEO data analysis, and ROC analysis highlighted CTSV and NOD1 as critical targets of these compounds, implicating pathways related to signal transduction, apoptosis, and immune response in their anti-DM effects.